- Home
- MBBC vs RADX Comparison
MBBC vs RADX Comparison
Compare MBBC & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBBC
- RADX
- Stock Information
- Founded
- MBBC 1902
- RADX 2021
- Country
- MBBC United States
- RADX Australia
- Employees
- MBBC N/A
- RADX N/A
- Industry
- MBBC Banks
- RADX
- Sector
- MBBC Finance
- RADX
- Exchange
- MBBC Nasdaq
- RADX NYSE
- Market Cap
- MBBC 29.3M
- RADX 32.5M
- IPO Year
- MBBC N/A
- RADX N/A
- Fundamental
- Price
- MBBC $10.03
- RADX $4.25
- Analyst Decision
- MBBC
- RADX Strong Buy
- Analyst Count
- MBBC 0
- RADX 2
- Target Price
- MBBC N/A
- RADX $13.50
- AVG Volume (30 Days)
- MBBC 10.4K
- RADX 22.4K
- Earning Date
- MBBC 08-22-2025
- RADX 02-26-2025
- Dividend Yield
- MBBC N/A
- RADX N/A
- EPS Growth
- MBBC 103.56
- RADX N/A
- EPS
- MBBC 0.22
- RADX N/A
- Revenue
- MBBC $6,591,743.00
- RADX $204,609.00
- Revenue This Year
- MBBC N/A
- RADX N/A
- Revenue Next Year
- MBBC N/A
- RADX N/A
- P/E Ratio
- MBBC $45.54
- RADX N/A
- Revenue Growth
- MBBC N/A
- RADX N/A
- 52 Week Low
- MBBC $6.38
- RADX $3.50
- 52 Week High
- MBBC $12.00
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- MBBC N/A
- RADX N/A
- Support Level
- MBBC N/A
- RADX N/A
- Resistance Level
- MBBC N/A
- RADX N/A
- Average True Range (ATR)
- MBBC 0.00
- RADX 0.00
- MACD
- MBBC 0.00
- RADX 0.00
- Stochastic Oscillator
- MBBC 0.00
- RADX 0.00
About MBBC Marathon Bancorp Inc. Common Stock
Marathon Bancorp Inc is a Wisconsin-chartered savings bank. It is a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the Company's revenues come from interest income on loans and debt securities.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.